Concepedia

Rafael Rech

RR

8

Publications

3.8K

Citations

8

H-Index

2009

Active since

Affiliations

Instituto Dante Pazzanese de Cardiologia(Current)

Pontifícia Universidade Católica do Rio Grande do Sul

University of Toronto

St. Michael's Hospital

Mossakowski Medical Research Institute, Polish Academy of Sciences

Rafael Rech is an author at Instituto Dante Pazzanese de Cardiologia specializing in medicine, metabolic syndrome, and diabetes.

Top concepts

Publications per year

2009–2022

8

Publications

8

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome

Otávio Berwanger, Eliana Vieira Santucci, Pedro Gabriel Melo de Barros e Silva et al. · JAMA · 2018 · 131 citations · Full text

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Implementation of a Brazilian Cardioprotective Nutritional (BALANCE) Program for improvement on quality of diet and secondary prevention of cardiovascular events: A randomized, multicenter trial

Bernardete Weber, Ângela Cristine Bersch-Ferreira, Camila Ragne Torreglosa et al. · American Heart Journal · 2019 · 48 citations · Full text

Rows per page

1–5 of 8